The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,612
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Self-citationSignaling Through Scaffold, Anchoring, and Adaptor Proteins
Pawson, T., & Scott, J. D. (1997) · Science · doi:10.1126/science.278.5346.2075 · Cited by 2,256
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,733
Sawyers, C. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401706 · Cited by 1,621
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249
Self-citationKhwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Tartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033
Crystal Structure of the Tyrosine Phosphatase SHP-2
Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 985
Tartaglia, M., Kalidas, K., Shaw, A., Song, X., Musat, D. L., van der Burgt, I., Brunner, H. G., Bertola, D. R., Crosby, A., Ion, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340847 · Cited by 802
Activation of the MAP kinase pathway by the protein kinase raf
Howe, L. R., Leevers, S. J., Gómez, N., Nakielny, S., Cohen, P., & Marshall, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90361-f · Cited by 801
Flint, A. J., Tiganis, T., Barford, D., & Tonks, N. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1680 · Cited by 774
Versatile retroviral vectors for potential use in gene therapy.
Hawley, R. G., Lieu, F. H., Fong, A. Z. C., & Hawley, T. S. (1994) · PubMed · Cited by 652
Bollag, G., Clapp, D. W., Shih, S., Adler, F., Zhang, Y. Y., Thompson, P., Lange, B. J., Freedman, M. H., McCormick, F., Jacks, T., et al. (1996) · Nature Genetics · doi:10.1038/ng0296-144 · Cited by 589
Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509
Self-citationCombinatorial control of the specificity of protein tyrosine phosphatases
Tonks, N. K., & Neel, B. G. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00196-4 · Cited by 501
Self-citationActivation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein.
Leevers, S. J., & Marshall, C. J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05088.x · Cited by 484
A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase.
Li, W., Nishimura, R., Kashishian, A., Batzer, A. G., Kim, W. J., Cooper, J. A., & Schlessinger, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.509 · Cited by 481
Harrison, D. A., Binari, R., Nahreini, T. S., Gilman, M., & Perrimon, N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07285.x · Cited by 469
Shp2 Regulates Src Family Kinase Activity and Ras/Erk Activation by Controlling Csk Recruitment
Zhang, S. Q., Yang, W., Kontaridis, M. I., Bivona, T. G., Wen, G., Araki, T., Luo, J., Thompson, J. A., Schraven, B. L., Philips, M. R., et al. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00050-4 · Cited by 447
Self-citationMutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Loh, M. L. (2004) · Blood · doi:10.1182/blood-2003-09-3287 · Cited by 427
Araki, T., Mohi, M. G., Ismat, F. A., Bronson, R. T., Williams, I. R., Kutok, J. L., Yang, W., Pao, L. I., Gilliland, D. G., Epstein, J. A., et al. (2004) · Nature Medicine · doi:10.1038/nm1084 · Cited by 420
Self-citationProtein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras.
Bennett, A. M., Tang, T. L., Sugimoto, S., Walsh, C. T., & Neel, B. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7335 · Cited by 397
Self-citationPerkins, L. A., Larsen, I., & Perrimon, N. (1992) · Cell · doi:10.1016/0092-8674(92)90098-w · Cited by 393
The ‘Gab’ in signal transduction
Gu, H., & Neel, B. G. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00002-3 · Cited by 388
Self-citationCritical role for Gab2 in transformation by BCR/ABL
Sattler, M., Mohi, M. G., Pride, Y. B., Quinnan, L. R., Malouf, N. A., Podar, K., Gesbert, F., Iwasaki, H., Li, S., Van Etten, R. A., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00074-0 · Cited by 364
Self-citationFreeman, R. M., Plutzky, J., & Neel, B. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11239 · Cited by 360
Self-citationForm and Function in Protein Dephosphorylation
Denu, J. M., Stuckey, J. A., Saper, M. A., & Dixon, J. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81356-2 · Cited by 330
Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2
Barford, D., & Neel, B. G. (1998) · Structure · doi:10.1016/s0969-2126(98)00027-6 · Cited by 321
Self-citationDevelopment of anticancer drugs targeting the MAP kinase pathway
Sebolt-Leopold, J. S. (2000) · Oncogene · doi:10.1038/sj.onc.1204083 · Cited by 320
Luo, H., Hanratty, W. P., & Dearolf, C. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07127.x · Cited by 315
Self-citationMolecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
Agazie, Y. M., & Hayman, M. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7875-7886.2003 · Cited by 306
Essential role for Gab2 in the allergic response
Gu, H., Saito, K., Klaman, L. D., Shen, J., Fleming, T., Wang, Y., Pratt, J. C., Lin, G., Lim, B., Kinet, J.-P., et al. (2001) · Nature · doi:10.1038/35084076 · Cited by 304
Self-citationBraun, B. S., Tuveson, D. A., Kong, N., Le, D. T., Kogan, S. C., Rozmus, J., Le Beau, M. M., Jacks, T. E., & Shannon, K. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307203101 · Cited by 299
Analysis of Ras-Induced Overproliferation in Drosophila Hemocytes
Asha, H., Nagy, I., Kovacs, G., Stetson, D., Ando, I., & Dearolf, C. R. (2003) · Genetics · doi:10.1093/genetics/163.1.203 · Cited by 296
Self-citationClinical pharmacokinetics and therapeutic drug monitoring of sirolimus
MacDonald, A., Scarola, J., Burke, J. T., & Zimmerman, J. J. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)89027-x · Cited by 292
Largaespada, D. A., Brannan, C. I., Jenkins, N. A., & Copeland, N. G. (1996) · Nature Genetics · doi:10.1038/ng0296-137 · Cited by 284
Zhang, S. Q., Tsiaras, W. G., Araki, T., Wen, G., Minichiello, L., Klein, R., & Neel, B. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4062-4072.2002 · Cited by 282
Self-citationChan, I. T., Kutok, J. L., Williams, I. R., Cohen, S., Kelly, L., Shigematsu, H., Johnson, L., Akashi, K., Tuveson, D. A., Jacks, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20476 · Cited by 270
Self-citationLu, W., Gong, D., Bar-Sagi, D., & Cole, P. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00369-0 · Cited by 268
Juvenile Myelomonocytic Leukemia
Aricò, M., Biondi, A., & Pui, C.-H. (1997) · Blood · doi:10.1182/blood.v90.2.479 · Cited by 250
Schwaller, J., Frantsve, J., Aster, J., Williams, I. R., Tomasson, M. H., Ross, T. S., Peeters, P., Van Rompaey, L., Van Etten, R. A., Ilaria, R., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5321 · Cited by 245
Self-citationMohi, M. G., Boulton, C., Gu, T.-L., Sternberg, D. W., Neuberg, D., Griffin, J. D., Gilliland, D. G., & Neel, B. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400063101 · Cited by 239
Self-citationAraki, T., Nawa, H., & Neel, B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306461200 · Cited by 231
Self-citationGoldfine, A. B. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3311 · Cited by 223
Sarkozy, A., Conti, E., Seripa, D., Digilio, M. C., Grifone, N., Tandoi, C., Fazio, V. M., Di Ciommo, V, Marino, B., Pizzuti, A., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.9.704 · Cited by 203
Gilliland, D. G., & Griffin, J. D. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00003 · Cited by 202
Self-citationLiu, Y., & Rohrschneider, L. R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02425-0 · Cited by 199
Occurrence of myeloproliferative disorder in patients with Noonan syndrome
Bader-Meunier, B., Tchernia, G., Miélot, F., Fontaine, J. L., Thomas, C., Lyonnet, S., Lavergne, J. M., & Dommergues, J. P. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70273-7 · Cited by 177
Le, D. T., Kong, N., Zhu, Y., Lauchle, J. O., Aiyigari, A., Braun, B. S., Wang, E., Kogan, S. C., Le Beau, M. M., Parada, L., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2650 · Cited by 175
Hanafusa, H., Torii, S., Yasunaga, T., Matsumoto, K., & Nishida, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312498200 · Cited by 174
Ren, Y., Meng, S., Mei, L., Zhao, Z. J., Jove, R., & Wu, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312575200 · Cited by 171
Gilliland, D. G., & Tallman, M. S. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00081-8 · Cited by 169
Self-citationBlood cells of Drosophila: cell lineages and role in host defence
Meister, M. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.002 · Cited by 168
Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressorPreprint
Cichowski, K. M., Santiago, S., Jardim, M. J., Johnson, B. W., & Jacks, T. (2003) · Genes & Development · doi:10.1101/gad.1054703 · Cited by 163
Identification of a Putative Syp Substrate, the PDGFβ Receptor
Klinghoffer, R. A., & Kazlauskas, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22208 · Cited by 157
Zhang, Y.-Y., Vik, T. A., Ryder, J. W., Srour, E. F., Jacks, T., Shannon, K., & Wade Clapp, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1893 · Cited by 150
Juvenile Myelomonocytic Leukemia and Noonan Syndrome
Choong, K. L. M., Freedman, M. H., Chitayat, D. A., Kelly, E., Taylor, G. P., & Zipursky, A. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199911000-00014 · Cited by 150
Requirement of Gab2 for mast cell development and KitL/c-Kit signaling.
Nishida, K., Wang, L., Morii, E., Park, S. J., Narimatsu, M., Itoh, S., Yamasaki, S., Fujishima, M., Ishihara, K., Hibi, M., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1866 · Cited by 148
Genetic analysis of protein tyrosine phosphatases
Vactor, D. V., O’Reilly, A. M., & Neel, B. G. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80070-1 · Cited by 143
Self-citationWelham, M. J., Dechert, U., Leslie, K. B., Jirik, F. R., & Schrader, J. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31581-8 · Cited by 139
Million, R. P., & Etten, R. A. V. (2000) · Blood · doi:10.1182/blood.v96.2.664 · Cited by 136
Ingram, D. A., Hiatt, K. K., King, A. J., Fisher, L., Shivakumar, R., Derstine, C., Wenning, M. J., Diaz, B., Travers, J. B., Hood, A. F., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.57 · Cited by 134
Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders
Pardanani, A. D., & Tefferi, A. (2004) · Blood · doi:10.1182/blood-2004-01-0246 · Cited by 131
Tyrosine kinase fusion genes in chronic myeloproliferative diseases
Cross, N. C. P., & Reiter, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402556 · Cited by 126
Activated Mutants of SHP-2 Preferentially Induce Elongation of Xenopus Animal Caps
O’Reilly, A. M., Pluskey, S., Shoelson, S. E., & Neel, B. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.299-311.2000 · Cited by 118
Self-citationMLL-rearranged leukemias: insights from gene expression profiling
Armstrong, S. A., Golub, T. R., & Korsmeyer, S. J. (2003) · Seminars in Hematology · doi:10.1016/s0037-1963(03)00196-3 · Cited by 79
Gu, H., Griffin, J. D., & Neel, B. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16421 · Cited by 79
Self-citationJuvenile myelomonocytic leukemia: molecular understanding and prospects for therapy
Emanuel, P. D., Shannon, K., & Castleberry, R. P. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)10044-7 · Cited by 75
Dearolf, C. R. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00031-0 · Cited by 65
Self-citationDonovan, S., See, W. L., Bonifas, J. M., Stokoe, D., & Shannon, K. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00214-3 · Cited by 62
Zinyk, D. L., McGonnigal, B., & Dearolf, C. R. (1993) · Nature Genetics · doi:10.1038/ng0693-195 · Cited by 33
Self-citationMyeloid disorders in infants with Noonan syndrome and a resident's "rule" recalled.
Side, L. E., & Shannon, K. (1997) · PubMed · Cited by 18
Cited by
Protein tyrosine phosphatases: from genes, to function, to disease
Tonks, N. K. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2039 · Cited by 1,677
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
Germline KRAS mutations cause Noonan syndrome
Schubbert, S., Zenker, M., Rowe, S. L., Böll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.-E., et al. (2006) · Nature Genetics · doi:10.1038/ng1748 · Cited by 730
Protein-tyrosine phosphatases and cancer
Östman, A., Hellberg, C., & Böhmer, F. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1837 · Cited by 657
MacKeigan, J. P., Murphy, L. O., & Blenis, J. (2005) · Nature Cell Biology · doi:10.1038/ncb1258 · Cited by 561
Metadata
- Authors
- Mohi, M. G., Williams, I. R., Dearolf, C. R., Chan, G., Kutok, J. L., Cohen, S., Morgan, K., Boulton, C., Shigematsu, H., Keilhack, H., Akashi, K., Gilliland, D. G., & Neel, B. G.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 7
- Issue
- 2
- Pages
- 179-191
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2011653532
- Cited by
- 277
- References
- 76
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.